Alrgn Bio Overview
- Founded
-
2014
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
Alrgn Bio General Information
Description
Operator of a food bioprocessing technology intended for hypoallergenic peanuts. The company's platform combines a patented food-grade enzymatic process with current food industry processing equipment to inactivate peanut allergens, enabling consumers with safer peanuts for a snack served to airplane passengers and peanut butter used in schools to a breakfast bar and a weightlifting powder.
Contact Information
Primary Industry
Food Products
Other Industries
Biotechnology
Other Consumer Non-Durables
Primary Office
- 2901 E Gate City Boulevard
- Suite 2400
- Greensboro, NC 27401
- United States
Alrgn Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 29-Jun-2017 | 00000 | Completed | Out of Business | ||
| 1. Seed Round | 16-Dec-2016 | 00000 | 00000 | 00.000 | Completed | Startup |
Alrgn Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | 0,000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Alrgn Bio Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
